Published date: 18 October 2018

Last edited date: 18 October 2018

Closed future opportunity - This means that a potential contract has passed its approach to market date. A buyer can choose to consider any supplier interest or convert this notice into an opportunity ready for live procurement.


Approach to market date: 6 November 2018

Contract summary

Industry

  • Blood coagulants - 33141530

Location of contract

Any region

Value of contract

£96,000,000

Procurement reference

CM/PHS/17/5534

Published date

18 October 2018

Approach to market date

6 November 2018

Contract start date

1 March 2019

Contract end date

28 February 2021

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

Recombinant Factor IX

More information

Spend profile

This table displays the spend profile of the notice
Financial year Budget
2018/2019 £4,000,000
2019/2020 £48,000,000
2020/2021 £44,000,000

About the buyer

Address

Commercial Medicines Unit - NHS England
2nd Floor, Rutland House
Runcorn
WA7 2ES
England

Email

alison.greenwood3@nhs.net